Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cannabics Pharmaceuticals Inc logo

Cannabics Pharmaceuticals Inc

CNBX
United States flag
OTCQB

Sector: Healthcare   

Industry: Biotechnology

0.09
 
USD
  
0.00
  
(3.07%)
Optionable: No  Market Cap: 12 M  90-day average vol: 109,293

Previous close: 0.08305  Open: 0.09  Bid:   Ask:
52 week range    
0.06   
   0.23
Peers   
IBIO / 
CMRX / 
ACOR / 
RXDX / 
Last updated: Thursday 14th April 2022

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics
Financials

CNBX Income Statement

Annual
Aug-13Aug-14Aug-16Aug-17Aug-18Aug-19Aug-20Aug-21Aug-22Aug-23
Amortization of intangibles4425.0
Basic EPS from continuing operations-2.4-3.59-0.42
Basic EPS total-2.4-3.59-0.42
Basic weighted shares outstanding5668.0430270.0860487.0919837.0120 M1 M1 M1 M1 M9 M
Cost of sales-112500.0-5684.0
Depreciation86.0-1577.0-7019.0-88440.0-188928.0-215155.0220926.0198527.0162061.0
Depreciation unreconciled86.0
DepreciationAndAmortization86.0-1577.0-7019.0-88440.0-188928.0-215155.0220926.0198527.0162061.0
Diluted EPS total-9.6-1.22.4-0.032.4-12.0-2.4-3.59-0.42
Diluted normalized net income/share-12.0-3.59-0.42
Diluted weighted shares outstanding5875.0225004.0805767.0126 M472070.01 M1 M1 M9 M
GainOnSaleOfSecurity-712.0-69027.064906.054077.0
GainsLossOnDisposalOfDiscontinuedOperations-50864.0
GeneralAndAdministrativeExpense9600.0195150.0214610.01 M2 M1 M1 M885791.02 M909980.0
Gross operating profit112500.05684.09601.09843.07157.029958.0410165.0
ImpairmentOfCapitalAssets4425.0
Income before tax-56401.0-219141.0-194681.0-2 M-4 M1 M-7 M126510.0-3 M-931380.0
InsuranceAndClaims57147.093192.068278.0
Interest income-27890.0-69027.0
InterestExpenseNonOperating179.0971.0-7178.0-4373.0-852.0-18348.0-8134.02391.01273.01174.0
MarketingExpense20245.015977.01223.0
MiscOtherSpecialCharges-26504.0-84315.031259.04 M-4 M594270.0782080.052623.0
Net income from total operations-56401.0-270005.0-194681.0-2 M-4 M1 M-7 M-3 M-4 M-4 M
NetIncomeCommonStockholders-56401.0-270005.0-194681.0-2 M-4 M1 M-7 M-3 M-4 M-4 M
NetIncomeContinuousOperations-56401.0-270005.0-194681.0-2 M-4 M1 M-7 M-3 M-4 M-4 M
NetIncomeDiscontinuousOperations-50864.0
NetIncomeFromOtherGainsLosses-769280.0-3 M
NetNonOperatingInterestIncomeExpense-179.0-971.0-27890.04373.0852.018348.08134.0-2391.0-1273.0-1174.0
NetOperatingInterestIncomeExpense-18348.0
NonRecurringOperationExpense48332.015500.0-140920.0-310750.0-247319.0-676096.0-828003.0487354.0443851.0149108.0
Normalized income587296.0-586682.0
Operating income-9600.0-195236.0-168177.0-2 M-4 M-3 M-3 M-3 M-3 M-931380.0
Operating income before depreciation (EBITDA)-56222.0-218084.0-180282.0-2 M-4 M1 M-7 M349827.0-3 M-768145.0
OperatingExpense-58111.0-216132.0-393177.0-2 M-4 M-3 M3 M3 M3 M1 M
Other income net27216.069027.0-64906.0-4 M4 M-594270.0-782080.0-52623.0
OtherGandA9600.0195150.0214610.01 M2 M1 M1 M885791.02 M909980.0
OtherOperatingExpenses107500.0
RentAndLandingFees100.040435.0214610.01 M2 M1 M
Research & development expense177607.0246943.01 M2 M2 M2 M1 M431565.0
ResearchExpense177607.0246943.01 M2 M2 M2 M1 M431565.0
Revenue per share4425.0-20000.0
SalariesAndWages-29850.0-880790.0-2 M-247307.0-220586.0142685.0379618.0461375.0
Selling Gen & administrative expense9600.0195150.0215570.02 M3 M2 M1 M828644.02 M909980.0
SellingAndMarketingExpense960.0287460.0422015.0288163.059997.020245.015977.01223.0
SellingExpense960.0287460.0422015.0288163.059997.0
Special income/charges-48332.0-19925.0140920.0310750.0247319.0676096.0828003.0-487354.0-443851.0-149108.0
Total Income available for interest expense (EBIT)-56222.0-218170.0-201859.0-2 M-4 M1 M-7 M128901.0-3 M-930206.0
Total common shares outstanding344670.0838611.0893515.0996373.0132 M1 M1 M1 M1 M28 M
Total net income-56401.0-270005.0-194681.0-2 M-4 M1 M-7 M-3 M-4 M-4 M
Total ordinary shares31 M31 M31 M31 M31 M31 M31 M31 M31 M31 M
Total revenues112500.05684.09601.09843.07157.029958.0410165.0
TotalExpenses-58111.0-216132.0-505677.0-2 M-4 M-3 M3 M3 M3 M1 M
TotalRevenue112500.05684.09601.09843.07157.029958.0410165.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University